Celsite� port and catheter as an intraperitoneal access device in the treatment of ovarian cancer

Topuz, Erkan; Salihoğlu, Yavuz; Aydıner, Adnan; Saip, Pınar; Taş, Faruk; Sozen, Tamer; Berkman, Sinan; Bengisu, Ergin

doi:10.1002/1096-9098(200007)74:3<223::aid-jso14>3.0.co;2-q

Cited by 15 publications

(18 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Complications of the Tenckhoff catheter such as infections and displacements are reported in the literature with a higher rate (20%) [12]. The Groshong valved catheter is reported to have a lower complication rate than the Tenckhoff [8].…”

Section: Discussionmentioning

confidence: 99%

Percutaneous placement of peritoneal port-catheter in oncologic patients

et al. 2004

View full text Add to dashboard Cite

The aim of this paper is to describe the technique of percutaneous ultrasound (US)-guided placement of a peritoneal port-catheter in an interventional radiological setting. Nineteen patients with peritoneal carcinomatosis were selected for intraperitoneal port-catheter placement in order to perform intracavitary receptor-immuno- or radio-immunotherapy with Ytrium-90. All the procedures were performed percutaneously under US and fluoro guidance; the insertion site for catheters was chosen according to abdominal conditions and US findings: all devices were implanted at the lower abdominal quadrants. All patients were followed up with CT and US according to the therapy protocol. The procedure was successfully completed in 15/19 patients, in 4 being contraindicated by peritoneal adhesions. No procedure-related complications and device occlusions during therapy were observed; one catheter displaced 7 months later the placement. In our experience, this procedure was feasible, reliable and easy to perform, allowing the correct administration of the planned intracavitary therapy. Peritoneal adhesions are the main limitation of peritoneal port placement.

show abstract

Section: Discussionmentioning

confidence: 99%

Percutaneous placement of peritoneal port-catheter in oncologic patients

et al. 2004

View full text Add to dashboard Cite

show abstract

“…The reporting of infections includes both superficial (skin cellulitis, portal pocket and catheter tunnel) and deep (intra‐abdominal abscess and peritonitis). The overall rates remain high at 0–20.5% 8,11,14–21,25–27,32 . The rate of peritonitis reported for ports manufactured by Pharmacia is 0.9–8.3%, 8,11,14,15,17 but peritonitis has not been reported in series using Bard ports.…”

Section: Infectionmentioning

confidence: 97%

“…Port‐A‐Cath is the current trademark of Smith Medical ASD Inc., St Paul, MN, USA (originally Pharmacia), but has become a byword for literally any venous or peritoneal access device. Of the publications in this review a minority specifically identify the port used with a manufacturer’s identification number 8,18,21–23 . For analysis of port experience this is probably not of any consequence, except with regard to the identification of the effect of fenestrations and cuffs.…”

Section: Port Development and Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Ports and complications for intraperitoneal chemotherapy delivery

Helm

2011

BJOG

View full text Add to dashboard Cite

Intraperitoneal access ports are essential to the delivery of chemotherapy agents into the peritoneal cavity of women with ovarian cancer, but their malfunction and adverse effects are frequently responsible for the failure to complete planned therapy. Complications, such as obstruction of the catheter, infection, leakage, rotation, retraction, and pain, together with bowel and vaginal perforation, cause delays in treatment, patient suffering and the expenditure of medical resources. A wide variety of ports have been used, including vascular access devices and intraperitoneal access devices. This paper reviews the development and use of ports for intraperitoneal chemotherapy, their complications and reported methods of prevention.

show abstract

“…With the resurgence of IPCT, there have been an increased number of complications during the placement and usage of intraperitoneal drug admin-istration (4)(5)(6)(7) . We describe a case of protrusion of a redundant catheter through the rectum, without any sign of peritonitis.…”

mentioning

confidence: 99%

A case of protrusion of an intraperitoneal chemotherapy catheter through rectum

Bilsel¹,

Balik²,

Bugra³

et al. 2005

Int J Gynecol Cancer

View full text Add to dashboard Cite

Bowel penetration of an intraperitoneal catheter occurred in a patient who had received a course of uncomplicated intraperitoneal chemotherapy for a persistent ovarian carcinoma. One month after the termination of chemotherapy, she presented with protrusion of a catheter through anus. At operation, the catheter was removed, the rectum was repaired primarily, and a cytoreductive surgery was performed.

show abstract

Celsite� port and catheter as an intraperitoneal access device in the treatment of ovarian cancer

Abstract: The complication rate of intraperitoneal access devices is comparatively low.

Cited by 15 publications

References 12 publications

Percutaneous placement of peritoneal port-catheter in oncologic patients

Percutaneous placement of peritoneal port-catheter in oncologic patients

Ports and complications for intraperitoneal chemotherapy delivery

A case of protrusion of an intraperitoneal chemotherapy catheter through rectum

Contact Info

Product

Resources

About